GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference

SOUTH SAN FRANCISCO, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco on Tuesday, April 10 at 9:00 a.m. Central European Time.

The presentation will be webcast live and available for replay from GBT’s website at www.gbt.com in the Investors section.

About GBTGBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information:Myesha Lacy (investors)GBT650-351-4730[email protected] 

Julie Normart (media)W2O pure415-946-1087[email protected]

Source: Global Blood Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The Garden Within Arrives at Nova Maldives for Festive Season 2026
• Best Crypto Presale to Buy in 2026: One Token Has $10.7 Million in Proof and a Listing Coming
• Kurly Expands Its Chef-Driven Food Collection with Udon Kaden's U.S. Retail Launch